Richtmann et al. showed that FAM83A is elevated in NSCLC and associated with poor prognosis, and is involved in proliferation, anchorage-independent growth, migration, and EGFR pathway activation in the tumor cells [39]. The gene discussed is EGFR; the disease is neoplasm.